Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19)

JAMA network open - Tập 3 Số 8 - Trang e2017539
Morayma Reyes Gil1, Mohammad Barouqa1, James Szymanski1, Jesus D. Gonzalez‐Lugo2, Shafia Rahman2, Henny H. Billett3,2
1Montefiore Medical Center, Department of Pathology, Albert Einstein College of Medicine, The Bronx, New York
2Montefiore Medical Center, Division of Hematology, Department of Medical Oncology, Albert Einstein College of Medicine, The Bronx, New York
3Montefiore Medical Center, Department of Medicine, Albert Einstein College of Medicine, The Bronx, New York

Tóm tắt

Từ khóa


Tài liệu tham khảo

Miyakis, 2006, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)., J Thromb Haemost, 4, 295, 10.1111/jth.2006.4.issue-2

Helms, 2020, High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study., Intensive Care Med, 46, 1089, 10.1007/s00134-020-06062-x

Tang, 2020, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia., J Thromb Haemost, 18, 844, 10.1111/jth.v18.4

Tang, 2020, Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy., J Thromb Haemost, 18, 1094, 10.1111/jth.v18.5

Bowles, 2020, Lupus anticoagulant and abnormal coagulation tests in patients with covid-19., N Engl J Med, 10.1056/NEJMc2013656

Schouwers, 2010, Lupus anticoagulant (LAC) testing in patients with inflammatory status: does C-reactive protein interfere with LAC test results?, Thromb Res, 125, 102, 10.1016/j.thromres.2009.09.001

Thông tin
Thông tin xuất bản

JAMA network open

Tập 3 Số 8

e2017539

Thông tin tác giả